8QU8: Von Hippel-Lindau disease tumor suppressor

PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1. Determined by electron microscopy at 3.5 Å resolution. Released 6 Dec 2023.

Method
Electron microscopy
Resolution
3.5 Å
Organism
Homo sapiens
Chains
6
Atoms
10,846
Mol. weight
169.49 kDa
Ligands
ZN, GDP, WYL
Released
6 Dec 2023

Explore 8QU8 in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8QU8 contains 62 α-helices and 36 β-strands across 6 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 5 helices, 12 β-strands

ElementResiduesLengthSheet
β-strand73-7861
β-strand84-8852
β-strand9612
α-helix99-1002
β-strand10112
α-helix1021
β-strand106-11051
β-strand117-12152
β-strand12712
β-strand129-13021
β-strand13311
β-strand14213
β-strand14513
β-strand147-15261
α-helix158-16912
α-helix183-1897
α-helix194-1996
Chain B: 4 helices, 7 β-strands
ElementResiduesLengthSheet
β-strand3-974
β-strand12-1874
β-strand2315
α-helix24-3512
β-strand43-4534
β-strand5014
β-strand5615
α-helix63-664
β-strand73-7864
α-helix92-998
α-helix101-1033
Chain C: 6 helices, 3 β-strands
ElementResiduesLengthSheet
β-strand18-2254
β-strand28-3254
α-helix33-364
α-helix40-467
β-strand60-6124
α-helix67-8317
α-helix91-944
α-helix97-993
α-helix100-11011
Chain D: 37 helices, 3 β-strands
ElementResiduesLengthSheet
α-helix13-2412
α-helix25-273
α-helix32-4615
α-helix54-7825
α-helix83-10422
α-helix106-12015
α-helix128-1336
α-helix139-15214
α-helix155-16713
α-helix169-1713
α-helix178-19013
α-helix201-2033
α-helix204-2085
α-helix209-22719
α-helix232-25322
α-helix256-2583
α-helix259-27012
α-helix275-2806
α-helix282-2876
α-helix291-30313
α-helix308-32821
α-helix337-35620
α-helix362-37615
α-helix387-3959
α-helix396-3983
α-helix411-42212
α-helix428-44518
α-helix455-46410
α-helix466-49429
β-strand507-51156
α-helix531-54818
α-helix5531
β-strand554-55526
β-strand56116
α-helix611-6155
α-helix664-68017
α-helix683-6908
α-helix696-6994
α-helix702-7076
α-helix715-72612
Chain E: 4 helices, 3 β-strands
ElementResiduesLengthSheet
β-strand27-3266
α-helix39-413
α-helix52-532
α-helix55-573
β-strand71-7227
β-strand78-7927
α-helix85-906
Chain F: 6 helices, 8 β-strands
ElementResiduesLengthSheet
β-strand3-1088
α-helix16-2510
β-strand38-4698
β-strand49-5798
α-helix66-738
β-strand77-8378
α-helix87-915
α-helix93-10412
β-strand111-11668
α-helix127-13711
β-strand141-14338
β-strand14519
β-strand15019
α-helix152-16817

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
von Hippel-Lindau disease tumor suppressorAprotein212Homo sapiensP40337 (AlphaFold model)
Elongin-BBprotein117Homo sapiensQ15370 (AlphaFold model)
Elongin-CCprotein111Homo sapiensQ15369 (AlphaFold model)
Cullin-2Dprotein744Homo sapiensQ13617 (AlphaFold model)
E3 ubiquitin-protein ligase RBX1, N-terminally processedEprotein107Homo sapiensP62877
GTPase KRasFprotein170Homo sapiensP01116
Sequence of entity 1 (A), FASTA
>8QU8_1 von Hippel-Lindau disease tumor suppressor (chains A)
PRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRP
VLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRD
AGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIV
RSLYEDLEDHPNVQKDLERLTQERIAHQRMGD
Sequence of entity 2 (B), FASTA
>8QU8_2 Elongin-B (chains B)
DVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECG
FTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ
Sequence of entity 3 (C), FASTA
>8QU8_3 Elongin-C (chains C)
DGEEKTYGGCEGPDAMYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVN
FREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC
Sequence of entity 4 (D), FASTA
>8QU8_4 Cullin-2 (chains D)
SLKPRVVDFDETWNKLLTTIKAVVMLEYVERATWNDRFSDIYALCVAYPEPLGERLYTET
KIFLENHVRHLHKRVLESEEQVLVMYHRYWEEYSKGADYMDCLYRYLNTQFIKKNKLTEA
DLQYGYGGVDMNEPLMEIGELALDMWRKLMVEPLQAILIRMLLREIKNDRGGEDPNQKVI
HGVINSFVHVEQYKKKFPLKFYQEIFESPFLTETGEYYKQEASNLLQESNCSQYMEKVLG
RLKDEEIRCRKYLHPSSYTKVIHECQQRMVADHLQFLHAECHNIIRQEKKNDMANMYVLL
RAVSTGLPHMIQELQNHIHDEGLRATSNLTQENMPTLFVESVLEVHGKFVQLINTVLNGD
QHFMSALDKALTSVVNYREPKSVCKAPELLAKYCDNLLKKSAKGMTENEVEDRLTSFITV
FKYIDDKDVFQKFYARMLAKRLIHGLSMSMDSEEAMINKLKQACGYEFTSKLHRMYTDMS
VSADLNNKFNNFIKNQDTVIDLGISFQIYVLQAGAWPLTQAPSSTFAIPQELEKSVQMFE
LFYSQHFSGRKLTWLHYLCTGEVKMNYLGKPYVAMVTTYQMAVLLAFNNSETVSYKELQD
STQMNEKELTKTIKSLLDVKMINHDSEKEDIDAESSFSLNMNFSSKRTKFKITTSMQKDT
PQEMEQTRSAVDEDRKMYLQAAIVRIMKARKVLRHNALIQEVISQSRARFNPSISMIKKC
IEVLIDKQYIERSQASADEYSYVA
Sequence of entity 5 (E), FASTA
>8QU8_5 E3 ubiquitin-protein ligase RBX1, N-terminally processed (chains E)
AAAMDVDTPSGTNSGAGKKRFEVKKWNAVALWAWDIVVDNCAICRNHIMDLCIECQANQA
SATSEECTVAWGVCNHAFHFHCISRWLKTRQVCPLDNREWEFQKYGH
Sequence of entity 6 (F), FASTA
>8QU8_6 GTPase KRas (chains F)
GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTA
GQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSD
LPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK

Ligands and cofactors

IDNameFormulaCopies
ZNZinc ionZn2
GDPGuanosine-5'-diphosphateC10 H15 N5 O11 P21
WYL(2S,4R)-1-[(2S)-2-[4-[4-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihyd…C50 H62 N14 O6 S21

Primary citation

Targeting cancer with small-molecule pan-KRAS degraders. Popow, J., Farnaby, W., Gollner, A. et al. Science (2024) 385:1338-1347. DOI 10.1126/science.adm8684 · PubMed

Other PDB entries of the same protein (UniProt P40337 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8QU8 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.